These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5037162)

  • 21. [Trivastal in diabetic vascular disorders].
    Guinet P; Poncet J
    Rev Lyon Med; 1969 Oct; 18(16):625-36. PubMed ID: 5400625
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term therapy of vascular permeability disorders using anthocyanosides].
    Neumann L
    Munch Med Wochenschr; 1973 May; 115(20):952-4. PubMed ID: 4740456
    [No Abstract]   [Full Text] [Related]  

  • 24. Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report.
    Girolami A; Peruffo R; Emanueli A
    Arzneimittelforschung; 1977; 27(6):1202. PubMed ID: 578441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy of pyridonolcarbamate in diabetic angiopathy].
    Furitano G; Cajozzo A; Notarbartolo A
    Minerva Med; 1975 Dec; 66(85):4599-602. PubMed ID: 1196545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of the action of a vascular protector on diabetic vascular fragility].
    Nove-Josserand G; Chirat P; Bussy L; Bonnamour C; Peaud PY; Ortonne JP; Gaillarde B; Plauchu M
    Lyon Med; 1971 Dec; 226(19):791-4. PubMed ID: 5159275
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of angioprotectors on the glomerular filtration rate and vascular permeability in diabetic angiopathies].
    Tirkina TN; Mirkhodzhaev AKh; Alekseev IuP; Ionushas BS; Kasymova SD
    Probl Endokrinol (Mosk); 1979; 25(4):11-6. PubMed ID: 471968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of betahistine hydrochloride in the treatment of peripheral vascular arterial disease.
    Allison RD; Barnes RN
    Tex Med; 1971 Nov; 67(11):85-92. PubMed ID: 5001167
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pyridinolcarbamate in diabetic angiopathies].
    Indovina I; Furitano G; Notarbartolo A; Citarrella P; Scaffidi A
    Minerva Med; 1978 May; 69(24):1681-97. PubMed ID: 566399
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemorheologic and retinal microcirculatory aspects of diabetics undergoing treatment with human insulin using microinfusors].
    Terranova R; Lombardo A; Spitaleri A; Motta L; Gorgone G; Amantia L
    Minerva Endocrinol; 1984; 9(2):197-203. PubMed ID: 6503906
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pyridinolcarbamate in the therapy of hemicrania syndromes].
    Spina A
    Acta Neurol (Napoli); 1972; 27(6):610-7. PubMed ID: 4651488
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immune and microcirculatory disorders in patients with diabetic retinopathy and their correction].
    Petrunia AM
    Vestn Oftalmol; 1996; 112(1):43-6. PubMed ID: 8659072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and laboratory examinations with Prodectin.
    Bédi J; Kosztovics A; Pálos LA
    Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
    [No Abstract]   [Full Text] [Related]  

  • 35. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
    Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of diabetic angiopathies].
    Efimov AS; Skrobonskaia NA; Danilova AI; Karabun PM; Lapko LI
    Ter Arkh; 1979; 51(12):99-104. PubMed ID: 538728
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 38. [Streptokinase-streptodornase association, a powerful therapeutic agent affecting the venous factor in obliterating arteritis of the lower limbs].
    Fux J; Cotin M
    Phlebologie; 1970; 23(3):303-5. PubMed ID: 5475594
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA; Fajardo JD; Velles Aguirre L; Quijano E; Ciliberti E; Lucarelli R
    Prensa Med Argent; 1970 Apr; 57(8):394-8. PubMed ID: 5517707
    [No Abstract]   [Full Text] [Related]  

  • 40. [Geriatric aspects of diabetes mellitus and diabetic angiopathies].
    Efimov ES
    Ter Arkh; 1983; 55(12):64-6. PubMed ID: 6665721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.